ACE393-103 Vaccination Challenge Study

NCT00859716 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Campylobacter Infection

Interventions

BIOLOGICAL: ACE393
BIOLOGICAL: Placebo vaccine

Sponsor

TD Vaccines A/S

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]